2 recruiting, 1 not yet recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 2, Not yet recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow LP-118: new trials by email Literature Review of LP-118 trials Research Report on LP-118
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For Adults With Newly-Diagnosed, BCR::ABL1-Positive Acute Lymphoblastic Leukemia (ALL) LP-118 - Philadelphia Positive Acute Lymphoblastic Leukemia | Phase 1 | Not yet recruiting | Wake Forest University Health Sciences | 26 | 2026-10-01 | 2026-06-05 |
| A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) LP-118, Ponatinib, Vincristine - Acute Leukemia, Lymphoblastic Leukemia | Phase 1 / Phase 2 | Recruiting | University of Chicago | 15 | 2024-09-13 | 2026-03-18 |
| Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL. LP-118 - Non Hodgkin Lymphoma, Richter Transformation | Phase 1 | Recruiting | Newave Pharmaceutical Inc | 100 | 2022-05-08 | 2026-05-05 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (3) · Hematologic Neoplasms (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Prolymphocytic, T-Cell (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Myelodysplastic-Myeloproliferative Diseases (1) · Neoplasms (1) · Primary Myelofibrosis (1) · Recurrence (1)
Newave Pharmaceutical Inc (1) · University of Chicago (1) · Wake Forest University Health Sciences (1)
United States (3)
P30CA012197 (1)